Bectumomab
|
WikiDoc Resources for Bectumomab |
|
Articles |
|---|
|
Most recent articles on Bectumomab |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Bectumomab at Clinical Trials.gov Clinical Trials on Bectumomab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Bectumomab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Bectumomab Discussion groups on Bectumomab Patient Handouts on Bectumomab Directions to Hospitals Treating Bectumomab Risk calculators and risk factors for Bectumomab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Bectumomab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Bectumomab (marketed under the trade name LymphoScan®) is a mouse monoclonal antibody and which it's used to treat non-Hodgkin's lymphoma. It has a radioisotope, technetium (99m TC) which it's added.